ControlCheck, Bluesight’s drug diversion monitoring solution, offers efficiency in confirming cases of drug diversion. Data from a newly released analysis indicates that the system identified 808 confirmed cases of drug diversion in 2023. Through artificial intelligence and machine learning analytics, the system offers health systems accuracy in identifying potential risks. Beyond its technological capabilities, the Bluesight diversion team also provides training and support to help hospitals achieve their diversion prevention goals.